CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints--analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood
CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inf...
Saved in:
Published in | Arthritis research & therapy Vol. 16; no. 2; p. R97 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
17.04.2014
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inflammatory activity in a contact-dependent manner, the analysis of synovial membrane (SM) is crucial. Published reports regarding this matter are lacking, so we investigated the distribution and phenotype of Tregs in concurrent samples of SM, SF and PB of RA patients in comparison to those of osteoarthritis (OA) patients.
Treg frequency in a total of 40 patients (18 RA and 22 OA) matched for age and sex was assessed by flow cytometry. Functional status was assessed by analysis of cell surface markers representative of activation, memory and regulation.
CD4⁺ T cells infiltrate the SM to higher frequencies in RA joints than in OA joints (P = 0.0336). In both groups, Tregs accumulate more within the SF and SM than concurrently in PB (P < 0.0001). Relative Treg frequencies were comparable in all compartments of RA and OA, but Treg concentration was significantly higher in the SM of RA patients (P = 0.025). Both PB and SM Tregs displayed a memory phenotype (CD45RO⁺RA⁻), but significantly differed in activation status (CD69 and CD62L) and markers associated with Treg function (CD152, CD154, CD274, CD279 and GITR) with only minor differences between RA and OA.
Treg enrichment into the joint compartment is not specific to inflammatory arthritis, as we found that it was similarly enriched in OA. RA pathophysiology might not be due to a Treg deficiency, because Treg concentration in SM was significantly higher in RA. Synovial Tregs represent a distinct phenotype and are activated effector memory cells (CD62L⁻CD69⁺), whereas peripheral Tregs are resting central memory cells (CD62L⁺CD69⁻). |
---|---|
AbstractList | CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inflammatory activity in a contact-dependent manner, the analysis of synovial membrane (SM) is crucial. Published reports regarding this matter are lacking, so we investigated the distribution and phenotype of Tregs in concurrent samples of SM, SF and PB of RA patients in comparison to those of osteoarthritis (OA) patients.
Treg frequency in a total of 40 patients (18 RA and 22 OA) matched for age and sex was assessed by flow cytometry. Functional status was assessed by analysis of cell surface markers representative of activation, memory and regulation.
CD4⁺ T cells infiltrate the SM to higher frequencies in RA joints than in OA joints (P = 0.0336). In both groups, Tregs accumulate more within the SF and SM than concurrently in PB (P < 0.0001). Relative Treg frequencies were comparable in all compartments of RA and OA, but Treg concentration was significantly higher in the SM of RA patients (P = 0.025). Both PB and SM Tregs displayed a memory phenotype (CD45RO⁺RA⁻), but significantly differed in activation status (CD69 and CD62L) and markers associated with Treg function (CD152, CD154, CD274, CD279 and GITR) with only minor differences between RA and OA.
Treg enrichment into the joint compartment is not specific to inflammatory arthritis, as we found that it was similarly enriched in OA. RA pathophysiology might not be due to a Treg deficiency, because Treg concentration in SM was significantly higher in RA. Synovial Tregs represent a distinct phenotype and are activated effector memory cells (CD62L⁻CD69⁺), whereas peripheral Tregs are resting central memory cells (CD62L⁺CD69⁻). INTRODUCTIONCD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inflammatory activity in a contact-dependent manner, the analysis of synovial membrane (SM) is crucial. Published reports regarding this matter are lacking, so we investigated the distribution and phenotype of Tregs in concurrent samples of SM, SF and PB of RA patients in comparison to those of osteoarthritis (OA) patients.METHODSTreg frequency in a total of 40 patients (18 RA and 22 OA) matched for age and sex was assessed by flow cytometry. Functional status was assessed by analysis of cell surface markers representative of activation, memory and regulation.RESULTSCD4⁺ T cells infiltrate the SM to higher frequencies in RA joints than in OA joints (P = 0.0336). In both groups, Tregs accumulate more within the SF and SM than concurrently in PB (P < 0.0001). Relative Treg frequencies were comparable in all compartments of RA and OA, but Treg concentration was significantly higher in the SM of RA patients (P = 0.025). Both PB and SM Tregs displayed a memory phenotype (CD45RO⁺RA⁻), but significantly differed in activation status (CD69 and CD62L) and markers associated with Treg function (CD152, CD154, CD274, CD279 and GITR) with only minor differences between RA and OA.CONCLUSIONSTreg enrichment into the joint compartment is not specific to inflammatory arthritis, as we found that it was similarly enriched in OA. RA pathophysiology might not be due to a Treg deficiency, because Treg concentration in SM was significantly higher in RA. Synovial Tregs represent a distinct phenotype and are activated effector memory cells (CD62L⁻CD69⁺), whereas peripheral Tregs are resting central memory cells (CD62L⁺CD69⁻). CD4.sup.+CD25.sup.+/highCD127.sup.low/- regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inflammatory activity in a contact-dependent manner, the analysis of synovial membrane (SM) is crucial. Published reports regarding this matter are lacking, so we investigated the distribution and phenotype of Tregs in concurrent samples of SM, SF and PB of RA patients in comparison to those of osteoarthritis (OA) patients. Treg frequency in a total of 40 patients (18 RA and 22 OA) matched for age and sex was assessed by flow cytometry. Functional status was assessed by analysis of cell surface markers representative of activation, memory and regulation. CD4.sup.+ T cells infiltrate the SM to higher frequencies in RA joints than in OA joints (P = 0.0336). In both groups, Tregs accumulate more within the SF and SM than concurrently in PB (P < 0.0001). Relative Treg frequencies were comparable in all compartments of RA and OA, but Treg concentration was significantly higher in the SM of RA patients (P = 0.025). Both PB and SM Tregs displayed a memory phenotype (CD45RO.sup.+RA.sup.-), but significantly differed in activation status (CD69 and CD62L) and markers associated with Treg function (CD152, CD154, CD274, CD279 and GITR) with only minor differences between RA and OA. Treg enrichment into the joint compartment is not specific to inflammatory arthritis, as we found that it was similarly enriched in OA. RA pathophysiology might not be due to a Treg deficiency, because Treg concentration in SM was significantly higher in RA. Synovial Tregs represent a distinct phenotype and are activated effector memory cells (CD62L.sup.-CD69.sup.+), whereas peripheral Tregs are resting central memory cells (CD62L.sup.+CD69.sup.-). Introduction CD4.sup.+CD25.sup.+/highCD127.sup.low/- regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid arthritis (RA) are contradictory and based on the analysis of peripheral blood (PB) and synovial fluid (SF). Because Tregs exert their anti-inflammatory activity in a contact-dependent manner, the analysis of synovial membrane (SM) is crucial. Published reports regarding this matter are lacking, so we investigated the distribution and phenotype of Tregs in concurrent samples of SM, SF and PB of RA patients in comparison to those of osteoarthritis (OA) patients. Methods Treg frequency in a total of 40 patients (18 RA and 22 OA) matched for age and sex was assessed by flow cytometry. Functional status was assessed by analysis of cell surface markers representative of activation, memory and regulation. Results CD4.sup.+ T cells infiltrate the SM to higher frequencies in RA joints than in OA joints (P = 0.0336). In both groups, Tregs accumulate more within the SF and SM than concurrently in PB (P < 0.0001). Relative Treg frequencies were comparable in all compartments of RA and OA, but Treg concentration was significantly higher in the SM of RA patients (P = 0.025). Both PB and SM Tregs displayed a memory phenotype (CD45RO.sup.+RA.sup.-), but significantly differed in activation status (CD69 and CD62L) and markers associated with Treg function (CD152, CD154, CD274, CD279 and GITR) with only minor differences between RA and OA. Conclusions Treg enrichment into the joint compartment is not specific to inflammatory arthritis, as we found that it was similarly enriched in OA. RA pathophysiology might not be due to a Treg deficiency, because Treg concentration in SM was significantly higher in RA. Synovial Tregs represent a distinct phenotype and are activated effector memory cells (CD62L.sup.-CD69.sup.+), whereas peripheral Tregs are resting central memory cells (CD62L.sup.+CD69.sup.-). |
ArticleNumber | R97 |
Audience | Academic |
Author | Zeifang, Felix Thomsen, Marc Rosshirt, Nils Schnatzer, Philipp Hagmann, Sébastien Kretzer, Jan Philippe Tretter, Theresa Moradi, Babak Lorenz, Hanns-Martin Gotterbarm, Tobias |
AuthorAffiliation | 1 University Clinic of Heidelberg, Clinic for Orthopedics and Trauma Surgery, Schlierbacher Landstr. 200a, 69118 Heidelberg, Germany 2 Klinikum Baden-Baden, Lilienmattstraße 5, 76530 Baden-Baden, Germany 3 University Clinic of Heidelberg, Department of Medicine V Div. of Rheumatology, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany |
AuthorAffiliation_xml | – name: 2 Klinikum Baden-Baden, Lilienmattstraße 5, 76530 Baden-Baden, Germany – name: 1 University Clinic of Heidelberg, Clinic for Orthopedics and Trauma Surgery, Schlierbacher Landstr. 200a, 69118 Heidelberg, Germany – name: 3 University Clinic of Heidelberg, Department of Medicine V Div. of Rheumatology, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany |
Author_xml | – sequence: 1 givenname: Babak surname: Moradi fullname: Moradi, Babak – sequence: 2 givenname: Philipp surname: Schnatzer fullname: Schnatzer, Philipp – sequence: 3 givenname: Sébastien surname: Hagmann fullname: Hagmann, Sébastien – sequence: 4 givenname: Nils surname: Rosshirt fullname: Rosshirt, Nils – sequence: 5 givenname: Tobias surname: Gotterbarm fullname: Gotterbarm, Tobias – sequence: 6 givenname: Jan Philippe surname: Kretzer fullname: Kretzer, Jan Philippe – sequence: 7 givenname: Marc surname: Thomsen fullname: Thomsen, Marc – sequence: 8 givenname: Hanns-Martin surname: Lorenz fullname: Lorenz, Hanns-Martin – sequence: 9 givenname: Felix surname: Zeifang fullname: Zeifang, Felix – sequence: 10 givenname: Theresa surname: Tretter fullname: Tretter, Theresa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24742142$$D View this record in MEDLINE/PubMed |
BookMark | eNptks1u1DAUhSNURH-AR0CWkBCLphM7duJskKoMFKRKbMracuybiavEHuykKMu-FjwE79AnwemUKZWQF7bO_c6xr3WPkwPrLCTJa5ydYcyLlfSUUfYsOcK05GmRF-Rgf2b0MDkO4TrLCKkIfZEcElpSgik5Sn7Xa3p3-7NeExa3VWc2Xb3GpOzdj9Xd7S_kYTP1cnR-RldIQd8HJD0gsN6oDjQyFvkOpiEiRsfS2HkzmghZjVwYwT1K187YMaSptLKfQxRci1oP3yewar43bDuwbpy3sMSG2bobI3s0wNB4aeH0UWr7abltsYA30eaj2PTO6ZfJ81b2AV497CfJt08fr-rP6eXXiy_1-WWqSMlZWnGucw2YAC7LipVESmBto3jZaNYo4AVjjEChM5JhSRUv2pLonFS8yHFZ8fwk-bDL3U7NAFqBHeMbxNabQfpZOGnE04o1ndi4G0GzIsP3Ae8fAryLXxBGMZiwfHDs1E1BYMY4IznLq4i-3aEb2YMwtnUxUS24OGc04zlhBYnU2X-ouDQMRsVpaU3Unxje7QzKuxA8tPvX40wsQyV2QxXBN__2usf-TlH-ByNGzyg |
CitedBy_id | crossref_primary_10_1186_s13075_020_02410_w crossref_primary_10_3389_fimmu_2017_00605 crossref_primary_10_4103_ejim_ejim_44_18 crossref_primary_10_1016_j_autrev_2014_10_012 crossref_primary_10_1371_journal_pone_0162306 crossref_primary_10_1016_j_molimm_2020_08_002 crossref_primary_10_3389_fimmu_2023_1154575 crossref_primary_10_4049_jimmunol_2300312 crossref_primary_10_4049_jimmunol_1701502 crossref_primary_10_3390_biomedicines10092111 crossref_primary_10_1186_s13075_017_1305_1 crossref_primary_10_3390_ijms22158005 crossref_primary_10_1038_s41467_023_40986_4 crossref_primary_10_54393_pbmj_v5i5_452 crossref_primary_10_3389_fgene_2021_721258 crossref_primary_10_3389_fphar_2022_952560 crossref_primary_10_1016_j_cyto_2014_11_020 crossref_primary_10_1111_cei_13230 crossref_primary_10_1007_s11914_017_0411_y crossref_primary_10_3390_jcm9051279 crossref_primary_10_1007_s10753_017_0577_6 crossref_primary_10_1038_s41584_021_00707_x crossref_primary_10_1016_j_coi_2017_08_005 crossref_primary_10_1007_s00018_022_04563_0 crossref_primary_10_1016_j_ebiom_2023_104751 crossref_primary_10_3389_fimmu_2022_907750 crossref_primary_10_1186_s13287_023_03380_x crossref_primary_10_2217_imt_2020_0071 crossref_primary_10_1007_s12026_023_09444_7 crossref_primary_10_1155_2015_751793 crossref_primary_10_1016_j_jaut_2019_102376 crossref_primary_10_3389_fimmu_2024_1312919 crossref_primary_10_1186_s13075_022_02827_5 crossref_primary_10_3390_ijms21176004 crossref_primary_10_3390_cells10030681 crossref_primary_10_23868_202110003 crossref_primary_10_1039_D3FO02954A crossref_primary_10_1111_crj_13527 crossref_primary_10_1007_s11926_018_0729_1 crossref_primary_10_1016_j_intimp_2020_106607 crossref_primary_10_3389_fgene_2022_1036156 crossref_primary_10_1007_s00223_019_00577_2 crossref_primary_10_1093_cei_uxac105 crossref_primary_10_1016_j_cyto_2023_156300 crossref_primary_10_3390_cells10051072 crossref_primary_10_3390_jcm9082423 crossref_primary_10_1155_2016_6579463 crossref_primary_10_4103_ijmr_IJMR_1676_18 crossref_primary_10_3389_fimmu_2023_1168818 crossref_primary_10_1038_nrrheum_2015_140 crossref_primary_10_1186_s13024_017_0222_8 crossref_primary_10_1126_sciadv_abo5284 crossref_primary_10_1038_s41467_017_02659_x crossref_primary_10_1186_s41927_020_00134_7 crossref_primary_10_1080_08820139_2018_1527852 crossref_primary_10_1371_journal_pone_0299521 crossref_primary_10_1016_j_biopha_2016_01_036 crossref_primary_10_14412_1995_4484_2016_660_666 crossref_primary_10_1002_jor_25453 crossref_primary_10_1002_jbio_201800120 crossref_primary_10_1186_s13075_019_2001_0 crossref_primary_10_1016_j_molimm_2023_10_002 crossref_primary_10_1038_s41577_024_00994_x crossref_primary_10_3389_fimmu_2023_1303640 crossref_primary_10_3390_ijms25137171 crossref_primary_10_1016_j_pbiomolbio_2017_12_004 crossref_primary_10_3389_fimmu_2021_649061 crossref_primary_10_3390_jcm8091343 crossref_primary_10_18699_SSMJ20230206 crossref_primary_10_3390_ijms23094848 crossref_primary_10_1111_cei_12486 crossref_primary_10_1007_s12016_023_08959_z crossref_primary_10_7197_223_v39i32356_369052 crossref_primary_10_1155_2018_9627806 crossref_primary_10_1073_pnas_1904271116 crossref_primary_10_1089_dna_2017_3771 crossref_primary_10_1007_s00018_021_04076_2 crossref_primary_10_1016_j_joca_2018_04_016 crossref_primary_10_3389_fmed_2022_992386 crossref_primary_10_1155_2015_171520 crossref_primary_10_1007_s00281_019_00741_8 crossref_primary_10_2174_1381612827666211104154459 crossref_primary_10_1016_j_vetimm_2020_110085 crossref_primary_10_25040_ecpb2019_03_044 crossref_primary_10_14412_1995_4484_2018_423_428 crossref_primary_10_3389_fimmu_2021_668095 crossref_primary_10_4049_jimmunol_1601708 crossref_primary_10_1007_s00482_018_0346_y crossref_primary_10_1016_j_biochi_2020_03_014 crossref_primary_10_1016_j_ocarto_2021_100193 crossref_primary_10_3389_fimmu_2023_1247710 crossref_primary_10_1007_s10753_019_00982_7 crossref_primary_10_3892_etm_2018_6885 crossref_primary_10_1155_2015_356040 crossref_primary_10_3389_fimmu_2017_00356 crossref_primary_10_1142_S0218957720500177 crossref_primary_10_1016_j_imlet_2024_106859 crossref_primary_10_1186_s13075_023_03041_7 |
Cites_doi | 10.1016/j.jim.2006.10.008 10.1038/70932 10.1084/jem.193.11.1285 10.1002/art.1780310302 10.1038/ni759 10.1084/jem.192.7.1027 10.1002/j.1460-2075.1992.tb05481.x 10.1084/jem.20060468 10.1136/ard.2003.013383 10.1038/nature01661 10.1136/ard.2006.068320 10.1186/ar1192 10.1016/j.exphem.2006.03.014 10.1002/eji.201041004 10.4049/jimmunol.155.3.1151 10.1002/art.20499 10.4049/jimmunol.167.3.1245 10.1146/annurev.immunol.18.1.423 10.1016/S1074-7613(02)00280-7 10.1080/03009740701482800 10.1016/j.cellimm.2008.05.007 10.1038/ni735 10.1016/S0092-8674(00)81109-5 10.1084/jem.20060772 10.1111/j.1365-2249.2005.02754.x 10.1093/rheumatology/kel089 10.1136/ard.2008.100768 10.1084/jem.20021139 10.1146/annurev.immunol.19.1.225 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M 10.1084/jem.193.11.1303 10.1084/jem.192.2.295 10.1093/intimm/8.5.765 10.1034/j.1600-065X.2001.1820102.x 10.1182/blood.V98.9.2736 10.1002/immu.200390024 10.3899/jrheum.110283 10.1126/science.1079490 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P |
ContentType | Journal Article |
Copyright | COPYRIGHT 2014 BioMed Central Ltd. Copyright © 2014 Moradi et al.; licensee BioMed Central Ltd. 2014 Moradi et al.; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2014 BioMed Central Ltd. – notice: Copyright © 2014 Moradi et al.; licensee BioMed Central Ltd. 2014 Moradi et al.; licensee BioMed Central Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1186/ar4545 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 1478-6354 |
EndPage | R97 |
ExternalDocumentID | A540832562 10_1186_ar4545 24742142 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -5E -5G -A0 -BR .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 AAFWJ AAJSJ ACGFS ACJQM ACRMQ ADBBV ADINQ ADUKV AEGXH AENEX AHBYD AHMBA AHSBF ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BFQNJ BMC C24 C6C CGR CS3 CUY CVF DIK E3Z EBD EBLON ECM EIF EJD EMOBN F5P GROUPED_DOAJ GX1 HYE HZ~ IAO IHR INH INR ITC KQ8 NPM O5R O5S O9- PGMZT PQQKQ RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A WOQ Z7U AAYXX CITATION 7X8 5PM AFPKN |
ID | FETCH-LOGICAL-c2785-988d3de12e1779572aae5fbc87bd5bce865552e6d0201a4c86f72d32986317983 |
IEDL.DBID | RPM |
ISSN | 1478-6354 |
IngestDate | Tue Sep 17 21:24:09 EDT 2024 Sat Oct 26 05:28:42 EDT 2024 Tue Nov 19 21:30:09 EST 2024 Tue Nov 12 23:34:54 EST 2024 Fri Nov 22 01:40:25 EST 2024 Sat Nov 02 12:29:11 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2785-988d3de12e1779572aae5fbc87bd5bce865552e6d0201a4c86f72d32986317983 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060198/ |
PMID | 24742142 |
PQID | 1558523539 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4060198 proquest_miscellaneous_1558523539 gale_infotracmisc_A540832562 gale_infotracacademiconefile_A540832562 crossref_primary_10_1186_ar4545 pubmed_primary_24742142 |
PublicationCentury | 2000 |
PublicationDate | 2014-Apr-17 |
PublicationDateYYYYMMDD | 2014-04-17 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-Apr-17 day: 17 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2014 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | D Cao (4183_CR13) 2004; 6 WF Ng (4183_CR31) 2001; 98 S Raghavan (4183_CR20) 2009; 68 H Jonuleit (4183_CR32) 2001; 193 RS McHugh (4183_CR34) 2002; 16 GS Firestein (4183_CR2) 2003; 423 Z Jiao (4183_CR17) 2007; 36 SY Kawashiri (4183_CR21) 2011; 38 GJ Freeman (4183_CR39) 2000; 192 MK Levings (4183_CR33) 2002; 196 N Seddiki (4183_CR9) 2006; 203 S Sakaguchi (4183_CR3) 1995; 155 C Baecher-Allan (4183_CR8) 2001; 167 JA Singh (4183_CR26) 2004; 63 JMR van Amelsfort (4183_CR14) 2004; 50 CH Kim (4183_CR27) 2006; 34 LA Stephens (4183_CR6) 2001; 31 J Shimizu (4183_CR35) 2002; 3 Y Ishida (4183_CR36) 1992; 11 S Read (4183_CR30) 2000; 192 D Dieckmann (4183_CR7) 2001; 193 S Hori (4183_CR23) 2003; 299 S Sakaguchi (4183_CR5) 2001; 182 EM Shevach (4183_CR4) 2000; 18 CA Lawson (4183_CR16) 2006; 45 LS Taams (4183_CR28) 2001; 31 RS Bystry (4183_CR25) 2001; 2 F Behrens (4183_CR18) 2007; 66 M Feldmann (4183_CR1) 1996; 85 FC Arnett (4183_CR22) 1988; 31 GM Han (4183_CR19) 2008; 253 D Cao (4183_CR12) 2003; 33 B Salomon (4183_CR29) 2001; 19 H Dong (4183_CR38) 1999; 5 Y Agata (4183_CR37) 1996; 8 DJ Hartigan-O’Connor (4183_CR10) 2007; 319 W Liu (4183_CR11) 2006; 203 M Möttönen (4183_CR15) 2005; 140 J Herrath (4183_CR24) 2011; 41 |
References_xml | – volume: 319 start-page: 41 year: 2007 ident: 4183_CR10 publication-title: J Immunol Methods doi: 10.1016/j.jim.2006.10.008 contributor: fullname: DJ Hartigan-O’Connor – volume: 5 start-page: 1365 year: 1999 ident: 4183_CR38 publication-title: Nat Med doi: 10.1038/70932 contributor: fullname: H Dong – volume: 193 start-page: 1285 year: 2001 ident: 4183_CR32 publication-title: J Exp Med doi: 10.1084/jem.193.11.1285 contributor: fullname: H Jonuleit – volume: 31 start-page: 315 year: 1988 ident: 4183_CR22 publication-title: Arthritis Rheum doi: 10.1002/art.1780310302 contributor: fullname: FC Arnett – volume: 3 start-page: 135 year: 2002 ident: 4183_CR35 publication-title: Nat Immunol doi: 10.1038/ni759 contributor: fullname: J Shimizu – volume: 192 start-page: 1027 year: 2000 ident: 4183_CR39 publication-title: J Exp Med doi: 10.1084/jem.192.7.1027 contributor: fullname: GJ Freeman – volume: 11 start-page: 3887 year: 1992 ident: 4183_CR36 publication-title: EMBO J doi: 10.1002/j.1460-2075.1992.tb05481.x contributor: fullname: Y Ishida – volume: 203 start-page: 1693 year: 2006 ident: 4183_CR9 publication-title: J Exp Med doi: 10.1084/jem.20060468 contributor: fullname: N Seddiki – volume: 63 start-page: 785 year: 2004 ident: 4183_CR26 publication-title: Ann Rheum Dis doi: 10.1136/ard.2003.013383 contributor: fullname: JA Singh – volume: 423 start-page: 356 year: 2003 ident: 4183_CR2 publication-title: Nature doi: 10.1038/nature01661 contributor: fullname: GS Firestein – volume: 66 start-page: 1151 year: 2007 ident: 4183_CR18 publication-title: Ann Rheum Dis doi: 10.1136/ard.2006.068320 contributor: fullname: F Behrens – volume: 6 start-page: R335 year: 2004 ident: 4183_CR13 publication-title: Arthritis Res Ther doi: 10.1186/ar1192 contributor: fullname: D Cao – volume: 34 start-page: 1033 year: 2006 ident: 4183_CR27 publication-title: Exp Hematol doi: 10.1016/j.exphem.2006.03.014 contributor: fullname: CH Kim – volume: 41 start-page: 2279 year: 2011 ident: 4183_CR24 publication-title: Eur J Immunol doi: 10.1002/eji.201041004 contributor: fullname: J Herrath – volume: 155 start-page: 1151 year: 1995 ident: 4183_CR3 publication-title: J Immunol doi: 10.4049/jimmunol.155.3.1151 contributor: fullname: S Sakaguchi – volume: 50 start-page: 2775 year: 2004 ident: 4183_CR14 publication-title: Arthritis Rheum doi: 10.1002/art.20499 contributor: fullname: JMR van Amelsfort – volume: 167 start-page: 1245 year: 2001 ident: 4183_CR8 publication-title: J Immunol doi: 10.4049/jimmunol.167.3.1245 contributor: fullname: C Baecher-Allan – volume: 18 start-page: 423 year: 2000 ident: 4183_CR4 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.18.1.423 contributor: fullname: EM Shevach – volume: 16 start-page: 311 year: 2002 ident: 4183_CR34 publication-title: Immunity doi: 10.1016/S1074-7613(02)00280-7 contributor: fullname: RS McHugh – volume: 36 start-page: 428 year: 2007 ident: 4183_CR17 publication-title: Scand J Rheumatol doi: 10.1080/03009740701482800 contributor: fullname: Z Jiao – volume: 253 start-page: 92 year: 2008 ident: 4183_CR19 publication-title: Cell Immunol doi: 10.1016/j.cellimm.2008.05.007 contributor: fullname: GM Han – volume: 2 start-page: 1126 year: 2001 ident: 4183_CR25 publication-title: Nat Immunol doi: 10.1038/ni735 contributor: fullname: RS Bystry – volume: 85 start-page: 307 year: 1996 ident: 4183_CR1 publication-title: Cell doi: 10.1016/S0092-8674(00)81109-5 contributor: fullname: M Feldmann – volume: 203 start-page: 1701 year: 2006 ident: 4183_CR11 publication-title: J Exp Med doi: 10.1084/jem.20060772 contributor: fullname: W Liu – volume: 140 start-page: 360 year: 2005 ident: 4183_CR15 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2005.02754.x contributor: fullname: M Möttönen – volume: 45 start-page: 1210 year: 2006 ident: 4183_CR16 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kel089 contributor: fullname: CA Lawson – volume: 68 start-page: 1908 year: 2009 ident: 4183_CR20 publication-title: Ann Rheum Dis doi: 10.1136/ard.2008.100768 contributor: fullname: S Raghavan – volume: 196 start-page: 1335 year: 2002 ident: 4183_CR33 publication-title: J Exp Med doi: 10.1084/jem.20021139 contributor: fullname: MK Levings – volume: 19 start-page: 225 year: 2001 ident: 4183_CR29 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.19.1.225 contributor: fullname: B Salomon – volume: 31 start-page: 1247 year: 2001 ident: 4183_CR6 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M contributor: fullname: LA Stephens – volume: 193 start-page: 1303 year: 2001 ident: 4183_CR7 publication-title: J Exp Med doi: 10.1084/jem.193.11.1303 contributor: fullname: D Dieckmann – volume: 192 start-page: 295 year: 2000 ident: 4183_CR30 publication-title: J Exp Med doi: 10.1084/jem.192.2.295 contributor: fullname: S Read – volume: 8 start-page: 765 year: 1996 ident: 4183_CR37 publication-title: Int Immunol doi: 10.1093/intimm/8.5.765 contributor: fullname: Y Agata – volume: 182 start-page: 18 year: 2001 ident: 4183_CR5 publication-title: Immunol Rev doi: 10.1034/j.1600-065X.2001.1820102.x contributor: fullname: S Sakaguchi – volume: 98 start-page: 2736 year: 2001 ident: 4183_CR31 publication-title: Blood doi: 10.1182/blood.V98.9.2736 contributor: fullname: WF Ng – volume: 33 start-page: 215 year: 2003 ident: 4183_CR12 publication-title: Eur J Immunol doi: 10.1002/immu.200390024 contributor: fullname: D Cao – volume: 38 start-page: 2517 year: 2011 ident: 4183_CR21 publication-title: J Rheumatol doi: 10.3899/jrheum.110283 contributor: fullname: SY Kawashiri – volume: 299 start-page: 1057 year: 2003 ident: 4183_CR23 publication-title: Science doi: 10.1126/science.1079490 contributor: fullname: S Hori – volume: 31 start-page: 1122 year: 2001 ident: 4183_CR28 publication-title: Eur J Immunol doi: 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P contributor: fullname: LS Taams |
SSID | ssj0022924 |
Score | 2.1253648 |
Snippet | CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in rheumatoid... Introduction CD4.sup.+CD25.sup.+/highCD127.sup.low/- regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the... CD4.sup.+CD25.sup.+/highCD127.sup.low/- regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs... INTRODUCTIONCD4⁺CD25⁺/highCD127low/⁻ regulatory T cells (Tregs) play a crucial role in maintaining peripheral tolerance. Data about the frequency of Tregs in... |
SourceID | pubmedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | R97 |
SubjectTerms | Aged Analysis Arthritis, Rheumatoid - blood Arthritis, Rheumatoid - immunology Female Flow Cytometry Humans Knee Joint - immunology Male Memory (Computers) Middle Aged Osteoarthritis - blood Osteoarthritis - immunology Phenotype Physiological aspects Synovial Fluid - immunology Synovial Membrane - immunology T-Lymphocytes, Regulatory - immunology |
Title | CD4⁺CD25⁺/highCD127low/⁻ regulatory T cells are enriched in rheumatoid arthritis and osteoarthritis joints--analysis of frequency and phenotype in synovial membrane, synovial fluid and peripheral blood |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24742142 https://search.proquest.com/docview/1558523539 https://pubmed.ncbi.nlm.nih.gov/PMC4060198 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLXaLhAbxJtAKUZCYlHSEMevLEcZqgppEIuO1F3k2I5m0IxTZWZAs-Mj-Co-gy_h2knahiWbLPyKFR_73uscHyP0rmKK68zy2IuRx7SubFwRZmJJc1LlhpiPQV1_9oVfzOnnK3Z1gNhwFiaQ9nW1PHOr9ZlbLgK38nqtk4EnlnydFdSLiOQyOUSHYH6HEL2Pskje3WRLITwCa0r7C4VSyaENCg6D1_-lEBGmlIyM0b9L8h2bNOZL3jFA5w_Rg95zxJOuh4_QgXWP0b1Z_2_8CfpdTOlpMSXsNPEaxMU0JWLV_Ehi3Hb3zTftHl9iv1O_waq1GJDjeaAGLx1uF3YHvmuzNJC1XQSlI6ycwf4MSHOb9K1Zuu3mz89fqhczwU2N67bjY-9DDU8aa_zOrm93s3fNd4A4Xts1xOXOfrhNqlc7_zpfBaZBkDdY4UCkf4rm558ui4u4v6kh1kRIFudSmszYlNhUiJwJopRldaWlqAyrtPWnXxmx3IBzmiqqJa8FMRnJJc-8Ylr2DB25xtkXCJsasMMzkQmTU0W0SrWlus6MqjnJKx6hN8OQldedIEcZAhnJy258I_Tej2TpZygMl1b9QQNo32tdlRNwUmEdA8cvQsejkjCz9Cj77YCF0md5OpqzzW5TghMmIYJnWR6h5x02bjozYCtCYoSamwJe0HucAzgPwt49rl_-d81X6D584MAsSsUxOtq2O_sanKZtdRI2G07CVIHnnEz-AlCZHb4 |
link.rule.ids | 230,314,727,780,784,864,885,27924,27925,53791,53793 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLVKkYAN4s1AoUZCYlHSIY6fy2qGqkCnYjGVuosc29EMmnGqzAxodnwEX8Vn8CVcO0nbsGQbP2LF59r3OsfnIvS2YJqbzPEkiJEntCxcUhBmE0kVKZQl9kNU15-c8ZNz-vmCXewg1t2FiaR9U8wP_WJ56OezyK28XJphxxMbfp2MaBARUXJ4C91mmVBpF6S3cRZRTS5bCgES7Ke0TSmUSg69UHAZggIwhZgwpaS3Hf27KN_YlfqMyRtb0PEDdL_1HfFRM8aHaMf5R-jOpP07_hj9Ho3pwWhM2MEwqBCPxikRi-rHMMF1k3G-qrd4isNZ_Qrr2mHATmCCWjz3uJ65DXiv1dxC0XoWtY6w9haHWyDV9aNv1dyvV39-_tKtnAmuSlzWDSN7G1sE2lgVznZDv6utr74DyPHSLSEy9-799aNysQmvC03AEKLAwQJHKv0TdH78cTo6SdpcDYkhQrJESWkz61LiUiEUE0Rrx8rCSFFYVhgX7r8y4rgF9zTV1EheCmIzoiTPgmZa9hTt-sq75wjbEtDDM5EJq6gmRqfGUVNmVpecqIIP0H43ZfllI8mRx1BG8ryZ3wF6F2YyDzYK02V0e9UA-g9qV_kRuKmwkoHrN0B7vZpgW6ZX_KbDQh6KAiHNu2qzysENkxDDs0wN0LMGG1eD6bA1QKKHmqsKQdK7XwJIj9LeLbJf_HfLfXT3ZDo5zU8_nX15ie7Bx448o1Tsod11vXGvwIVaF6-jwfwF_dUfNQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dbtMwFLZgSBM3iH8KgxkJiYuRZXH8l8uppRo_nXaxSbuLHNtRg1qnSltQ73gInorH4Ek4dtKt4ZLbHNux4s_2Oc7n7yD0rmCK69TyyIuRR7QsbFQQZiJJM1JkhpiToK4_OednV_TzNbveSfUVSPu6qI7dbH7sqmngVi7mOt7yxOKLyZB6EZFMxgtTxnfRPZYCyLaBehdrkazNZ0shSII9lXZphRLJoSUKboNXAaYQFyaU9LakfxfmnZ2pz5rc2YbGD9GDzn_Ep20_H6E71j1G-5PuD_kT9Hs4okfDEWFHsVciHo4SImb1jzjCTZt1vm42-BL78_olVo3FgB_PBjW4criZ2jV4sHVlwLSaBr0jrJzB_iZIffvoW1251fLPz1-qkzTBdYnLpmVlb0INTx2r_fmub3e5cfV3ADqe2zlE585-uH1Uztb-db4KTIYgcjDDgU7_FF2NP14Oz6IuX0OkiZAsyqQ0qbEJsYkQGRNEKcvKQktRGFZo6-_AMmK5ARc1UVRLXgpiUpJJnnrdtPQZ2nO1sy8QNiUgiKciFSajimiVaEt1mRpVcpIVfIAOt0OWL1pZjjyEM5Ln7fgO0Hs_krmfpzBcWnXXDaB9r3iVn4KrCqsZuH8DdNArCfNL98xvt1jIvcmT0pyt18scXDEJcTxLswF63mLjpjNbbA2Q6KHmpoCX9e5bAO1B3rtD98v_rnmI9i9G4_zrp_Mvr9B9-NaBapSIA7S3atb2NXhRq-JNmC9_Af7hIEg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CD4%2BCD25%2B%2FhighCD127low%2F-+regulatory+T+cells+are+enriched+in+rheumatoid+arthritis+and+osteoarthritis+joints%E2%80%94analysis+of+frequency+and+phenotype+in+synovial+membrane%2C+synovial+fluid+and+peripheral+blood&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Moradi%2C+Babak&rft.au=Schnatzer%2C+Philipp&rft.au=Hagmann%2C+S%C3%A9bastien&rft.au=Rosshirt%2C+Nils&rft.date=2014-04-17&rft.issn=1478-6354&rft.eissn=1478-6354&rft.volume=16&rft.issue=2&rft_id=info:doi/10.1186%2Far4545&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_ar4545 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6354&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6354&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6354&client=summon |